These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 17934858)

  • 21. Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome: A Bridge between Functional Organic Dichotomy.
    Ghoshal UC; Shukla R; Ghoshal U
    Gut Liver; 2017 Mar; 11(2):196-208. PubMed ID: 28274108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rifaximin treatment for symptoms of irritable bowel syndrome.
    Fumi AL; Trexler K
    Ann Pharmacother; 2008 Mar; 42(3):408-12. PubMed ID: 18303148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Small intestine bacterial overgrowth in irritable bowel syndrome: a retrospective study with rifaximin.
    Cuoco L; Salvagnini M
    Minerva Gastroenterol Dietol; 2006 Mar; 52(1):89-95. PubMed ID: 16554709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rifaximin treatment for the irritable bowel syndrome with a positive lactulose hydrogen breath test improves symptoms for at least 3 months.
    Meyrat P; Safroneeva E; Schoepfer AM
    Aliment Pharmacol Ther; 2012 Dec; 36(11-12):1084-93. PubMed ID: 23066911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Results of small intestinal bacterial overgrowth testing in irritable bowel syndrome patients: clinical profiles and effects of antibiotic trial.
    Majewski M; McCallum RW
    Adv Med Sci; 2007; 52():139-42. PubMed ID: 18217406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy.
    Lombardo L; Foti M; Ruggia O; Chiecchio A
    Clin Gastroenterol Hepatol; 2010 Jun; 8(6):504-8. PubMed ID: 20060064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breath test for differential diagnosis between small intestinal bacterial overgrowth and irritable bowel disease: an observation on non-absorbable antibiotics.
    Esposito I; de Leone A; Di Gregorio G; Giaquinto S; de Magistris L; Ferrieri A; Riegler G
    World J Gastroenterol; 2007 Dec; 13(45):6016-21. PubMed ID: 18023092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A meta-analysis on small intestinal bacterial overgrowth in patients with different subtypes of irritable bowel syndrome.
    Ghoshal UC; Nehra A; Mathur A; Rai S
    J Gastroenterol Hepatol; 2020 Jun; 35(6):922-931. PubMed ID: 31750966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical trial: the combination of rifaximin with partially hydrolysed guar gum is more effective than rifaximin alone in eradicating small intestinal bacterial overgrowth.
    Furnari M; Parodi A; Gemignani L; Giannini EG; Marenco S; Savarino E; Assandri L; Fazio V; Bonfanti D; Inferrera S; Savarino V
    Aliment Pharmacol Ther; 2010 Oct; 32(8):1000-6. PubMed ID: 20937045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Symptom Severity Following Rifaximin and the Probiotic VSL#3 in Patients with Chronic Pelvic Pain Syndrome (Due to Inflammatory Prostatitis) Plus Irritable Bowel Syndrome.
    Vicari E; Salemi M; Sidoti G; Malaguarnera M; Castiglione R
    Nutrients; 2017 Nov; 9(11):. PubMed ID: 29099760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Positive glucose breath testing is more prevalent in patients with IBS-like symptoms compared with controls of similar age and gender distribution.
    Parodi A; Dulbecco P; Savarino E; Giannini EG; Bodini G; Corbo M; Isola L; De Conca S; Marabotto E; Savarino V
    J Clin Gastroenterol; 2009; 43(10):962-6. PubMed ID: 19525858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Total Bilirubin Is Associated with Small Intestinal Bacterial Overgrowth in Diarrhea Predominant Irritable Bowel Syndrome.
    Kim SY; Seo YS; Lee ES; Kim KN
    Ann Clin Lab Sci; 2019 May; 49(3):344-352. PubMed ID: 31308034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome.
    Posserud I; Stotzer PO; Björnsson ES; Abrahamsson H; Simrén M
    Gut; 2007 Jun; 56(6):802-8. PubMed ID: 17148502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Small intestinal bacterial overgrowth in irritable bowel syndrome: association with colon motility, bowel symptoms, and psychological distress.
    Grover M; Kanazawa M; Palsson OS; Chitkara DK; Gangarosa LM; Drossman DA; Whitehead WE
    Neurogastroenterol Motil; 2008 Sep; 20(9):998-1008. PubMed ID: 18482250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A proof-of-concept study showing antibiotics to be more effective in irritable bowel syndrome with than without small-intestinal bacterial overgrowth: a randomized, double-blind, placebo-controlled trial.
    Ghoshal UC; Srivastava D; Misra A; Ghoshal U
    Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):281-9. PubMed ID: 26731696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Variation of intestinal fermentative profile after sequential therapy with rifaximin/probiotics].
    Dima G; Peralta D; Novillo A; Lasa J; Besasso H; Soifer L
    Acta Gastroenterol Latinoam; 2012 Jun; 42(2):99-104. PubMed ID: 22876711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does Carbohydrate Challenge Testing Predict Clinical Response in Small Intestinal Bacterial Overgrowth?
    Long SK; Di Palma JA
    South Med J; 2016 May; 109(5):296-9. PubMed ID: 27135726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A link between irritable bowel syndrome and fibromyalgia may be related to findings on lactulose breath testing.
    Pimentel M; Wallace D; Hallegua D; Chow E; Kong Y; Park S; Lin HC
    Ann Rheum Dis; 2004 Apr; 63(4):450-2. PubMed ID: 15020342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of a Preparation of Four Probiotics on Symptoms of Patients with Irritable Bowel Syndrome: Association with Intestinal Bacterial Overgrowth.
    Leventogiannis K; Gkolfakis P; Spithakis G; Tsatali A; Pistiki A; Sioulas A; Giamarellos-Bourboulis EJ; Triantafyllou K
    Probiotics Antimicrob Proteins; 2019 Jun; 11(2):627-634. PubMed ID: 29508268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Obesity Is Inversely Related to Hydrogen-Producing Small Intestinal Bacterial Overgrowth in Non-Constipation Irritable Bowel Syndrome.
    Jung SE; Joo NS; Han KS; Kim KN
    J Korean Med Sci; 2017 Jun; 32(6):948-953. PubMed ID: 28480652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.